Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

This study is testing a new injectable medication called efsubaglutide alfa to see if it helps adults with overweight or obesity lose weight. About 200 participants will receive either the drug or a placebo (a dummy injection) for 22 weeks to compare results. Researchers will mea…